Waddell & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Waddell & Associates's LLY Position: Q2 2026 in Review
Waddell & Associates reduced its Eli Lilly (LLY) stake by 0.35% in Q2 2026, selling an estimated $19.4K and leaving 5,432 shares worth $6.52M. The position accounts for 0.32% of the portfolio, ranked #25.
Waddell & Associates first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. 1,692 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Waddell & Associates held 5,432 shares of Eli Lilly worth $6.52M as of Q2 2026.
- Waddell & Associates sold 19 Eli Lilly shares in Q2 2026, an estimated $19.4K.
- Eli Lilly made up 0.32% of Waddell & Associates's portfolio in Q2 2026, its #25 holding.
- Waddell & Associates first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
- 1,692 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.